Literature DB >> 9284827

Lymphocyte apoptosis during early phase of Listeria infection in mice.

J C Merrick1, B T Edelson, V Bhardwaj, P E Swanson, E R Unanue.   

Abstract

During the acute phase of growth of Listeria monocytogenes in spleen and lymph nodes, the infective foci consist of macrophages and neutrophils accompanied by extensive death of lymphocytes. Many of the lymphocytes die by apoptosis. The lesions are found by 48 hours after infection and can regress with time. Depending on the dose, the infected foci can be restricted to the thymus-dependent areas or can occupy the entire lymphoid tissue. The Listeria in the lesions are primarily found inside macrophages, but a few are extracellular amid cellular debris. Lymphocyte death appears to be an obligatory step in primary Listeria infection, the extent of which is controlled by the early restriction of Listeria growth by the innate cellular system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284827      PMCID: PMC1857845     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

Authors:  K C Sheehan; N H Ruddle; R D Schreiber
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

2.  Establishment of monoclonal anti-Nk-1.1 antibody.

Authors:  G C Koo; J R Peppard
Journal:  Hybridoma       Date:  1984

3.  Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.

Authors:  K Hestdal; F W Ruscetti; J N Ihle; S E Jacobsen; C M Dubois; W C Kopp; D L Longo; J R Keller
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

4.  Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.

Authors:  H W Rogers; K C Sheehan; L M Brunt; S K Dower; E R Unanue; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

5.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

Review 6.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

Authors:  P L Cohen; R A Eisenberg
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

7.  Resistance and susceptibility of mice to bacterial infection: histopathology of listeriosis in resistant and susceptible strains.

Authors:  T E Mandel; C Cheers
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

8.  Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes.

Authors:  K P Beckerman; H W Rogers; J A Corbett; R D Schreiber; M L McDaniel; E R Unanue
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

9.  Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Authors:  N A Buchmeier; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.

Authors:  W Y Ho; M P Cooke; C C Goodnow; M M Davis
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  49 in total

Review 1.  The concept of space and competition in immune regulation.

Authors:  Brigitta Stockinger; Thomas Barthlott; George Kassiotis
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

2.  Sex-dependent susceptibility to Listeria monocytogenes infection is mediated by differential interleukin-10 production.

Authors:  Bastian Pasche; Svetoslav Kalaydjiev; Tobias J Franz; Elisabeth Kremmer; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabé de Angelis; Andreas Lengeling; Dirk H Busch
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

5.  The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.

Authors:  Stacey L Mueller-Ortiz; John E Morales; Rick A Wetsel
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 6.  Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.

Authors:  Daniel G Calame; Stacey L Mueller-Ortiz; Rick A Wetsel
Journal:  Immunobiology       Date:  2016-07-16       Impact factor: 3.144

7.  Lymphocytes serve as a reservoir for Listeria monocytogenes growth during infection of mice.

Authors:  Denise S McElroy; Taylor J Ashley; Sarah E F D'Orazio
Journal:  Microb Pathog       Date:  2009-02-07       Impact factor: 3.738

8.  Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity.

Authors:  Erin Theisen; John-Demian Sauer
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

9.  Decreased susceptibility of mice to infection with Listeria monocytogenes in the absence of interleukin-18.

Authors:  Matthias Lochner; Kathrin Kastenmüller; Michael Neuenhahn; Heike Weighardt; Dirk H Busch; Wolfgang Reindl; Irmgard Förster
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

10.  Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes.

Authors:  Anna T Reinicke; Kyla D Omilusik; Genc Basha; Wilfred A Jefferies
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.